Therefore, we would presume that EGFR could be activated by elevated intracellular ROS in response to viral infection, and establishing pseudoviruses (i.e. inactivated viruses) targeting malignant cells may arrest cancer cells at certain cell cycle stages through the same mechanism for the sake of therapeutics. The gene discussed is EGFR; the disease is cancer.